A technology that is adapted to the special conditions for wave energy places the wave energy technology from Uppsala on the absolute cutting edge in the world. In his dissertation, Rafael Waters presents the findings from the experimental facility located in the sea outside Lysekil, Sweden, in which he has played a leading role in designing and constructing. He is publicly defending his dissertation at Uppsala University on December 12.
Body
A potent combination of powerful new analysis methods and abundant data from genomics projects is carrying microbiology forward into a new era. Bacteria in particular are shedding light on fundamental molecular and signalling processes of interest not just within microbiology, but across the whole spectrum of life sciences embracing higher organisms, including plants and vertebrates.
Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.
Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have identified a key step required for cell division in a study that could help improve therapies to treat cancer. Their work describing the mechanism of the contractile ring – a structure that pinches the mother cell into two daughter cells – has been published in the December 5 issue of the journal Science.
PASADENA, Calif.--Using novel imaging, labeling, and data-analysis techniques, scientists from the California Institute of Technology (Caltech) have been able to visualize, for the first time, large numbers of cells moving en masse during some of the earliest stages of embryonic development.
An international coalition of pediatric cancer physicians and researchers has developed new systems to standardize studies of neuroblastomas across the world. In the December issue of the Journal of Clinical Oncology, the International Neuroblastoma Risk Group (INRG) presents three sets of papers outlining a: standard classification system; pre-treatment staging system; and an analysis of a rare group of patients.
The INRG studies provide for a unified system of clinical trials that will enable quicker identification of optimal treatments for neuroblastoma.
Combination therapies similar to those used for HIV patients may be the best way of treating hepatitis C virus (HCV), say researchers from the University of Leeds.
A study of a protein called p7, has revealed that differences in the genetic coding of the protein between virus strains - known as genotypes - alter the sensitivity of the virus to drugs that block its function.
Injection drug users sentenced to compulsory detention under China's paradoxical policies on HIV/AIDS and narcotics suffer human rights abuses that may imperil their health, says a new study published in the open access journal PLoS Medicine.
The next generation of case management guidelines for childhood illness need to be more locally informed, rather than relying on those centrally generated by organizations like the World Health Organization (WHO), argues a new essay published in the open access journal PLoS Medicine.
Microsporidia are single-celled parasites that are capable of causing infections in humans - primarily people with compromised immune systems, such as those infected with HIV or who have undergone organ transplants. An article in this week's issue of PLoS Biology documents a newly discovered species of microsporidia, which infects C. elegans, the round worm used as a model system by developmental biologists. The work, undertaken by a team of French and American scientists led by Professor Frederick Ausubel and Dr.
ROCHESTER, Minn. -- Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a Mayo Clinic study presented today at the50th Annual Meeting of the American Society of Hematology (http://www.hematology.org/meetings/2008/) in San Francisco. In fact, statins may slow the progression of certain types of lymphoma.
An international team of biologists has discovered a new species of microsporidia, a single-celled parasite of animals, in a roundworm used in genetic laboratories around the world.
The discovery, detailed in the current issue of the journal PLoS Biology, is a breakthrough for public health researchers who until now had been looking for a suitable laboratory model in which to study microsporidia—a class of emerging pathogens that can cause significant illness in humans.
Scientists have uncovered vital clues about how to treat serious bowel disorders by studying the behaviour of cells in the colon.
Researchers at the University of Edinburgh believe a chemical messenger that is essential for developing a baby's gut in the womb could hold the key to new treatments for inflammatory bowel disease (IBD), a condition which affects 1 in 250 people in the UK.
The team studied a chain of chemical reactions inside colon cells, called the Hedgehog signalling pathway, which controls the way it behaves and communicates with other cells.
SAN FRANCISCO - A new risk model for myelodysplastic syndrome provides survival projections that apply to patients at any stage of the disease, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th Annual Meeting of the American Society of Hematology.
"The previous prognostic model for MDS applies only to the newly diagnosed patient, so once therapy begins or the disease progresses, it cannot help guide our decisions," said study lead author Hagop Kantarjian, M.D., chair of M. D. Anderson's Department of Leukemia.
New data from a long-term, prospective study show that among people who were surgically treated for colorectal cancer, pre-diagnosis blood levels of two insulin-related proteins predicted the risk of subsequent death. Researchers found that patients with high pre-diagnosis levels of insulin-like growth factor binding protein-1 (IGFBP-1) had a more than 50 percent reduced risk of overall death and colorectal cancer death; conversely, high levels of C-peptide, a marker of insulin production, were associated with nearly twice the overall risk of death.